Trial Profile
Food-Effect Pharmacokinetic Study of PL2200 (VAZALOR) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Feb 2021
Price :
$35
*
At a glance
- Drugs Aspirin (Primary)
- Indications Cardiovascular disorders; Pain
- Focus Pharmacokinetics
- Sponsors PLx Pharma
- 21 Feb 2020 Results presented at the International Stroke Conference 2020
- 21 Feb 2020 According to a PLx Pharma media release, data from this study was published in the Journal of Thrombosis and Thrombolysis.
- 21 Feb 2020 According to a PLx Pharma media release, data from this study were presented at the International Stroke Conference.